FEMY vs JAZZ · rev $1.6M vs P/E 1988, rev $2.28B
Femasys Inc (FEMY) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Femasys Inc (FEMY) is a medical instruments & supplies company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FEMY revenue for 2024-12-31 was $1.6M. Net income was -$18.8M. Revenue was up 52.0% from 2023-12-31 to 2024-12-31. FEMY currently screens at market cap $925.2K.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FEMY currently screens at market cap $925.2K. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FEMY and JAZZ stock pages for the full models.
Not investment advice.